Biotech: Study Undermines Case For Antidepressants

Having trouble reading this e-mail? Click here for mobile version.

FORBES.COM BIOTECH NEWSLETTER JANUARY 06, 2010
Study Undermines Case For Antidepressants Robert Langreth Drugs are hardly better than a placebo for the mildly depressed, researchers find. Tom Van Riper On Retailing Tom Van Riper The 2010 back-to-school and holiday shopping seasons will be even worse than those of 2008 and 2009. Matthew Herper And Robert Langreth On The Pharmaceutical Industry Matthew Herper and Robert Langreth Usually, the trend is toward mega-mergers and spin-outs. But in 2010, a major drug company will break up. David Whelan On Health Care Reform David Whelan Future decision making will be like water in the Potomac. Everything will run through Washington. Sanofi's Allegra Gambit Helen Coster and Matthew Herper By buying Chattem, Sanofi-Aventis gets skilled marketers who can launch its allergy drug in the lucrative U.S. over-the-counter market.	ADVERTISEMENT
Forbes Magazine Special Offer! Forbes.com Newsletter readers receive a Free Trial Issue of Forbes... no risk... no obligation! If you decide to subscribe to Forbes, you can do so at special introductory savings, and get 25 more issues - 26 in all - for just $1.15 a copy. You save 77% off the $4.99 newsstand price. If you decide Forbes is not for you, simply write cancel on the invoice you receive and return it. The FREE issue is yours to keep with our compliments. Sign up Today for your Free Trial Issue! © 2010 Forbes.com LLC.™